News

The Ai-medlab team took part in the Iran International Exhibition of Pharmaceuticals and Related Industries, a major event that brings together innovators, researchers, and companies shaping the future of healthcare and medical technology. During the exhibition, the Ai-medlab team had the opportunity to engage with healthcare professionals and industry experts,

On September 25, 2025, Ai-MedLab took part in the Angel & Accelerator Virtual Conference, a global online event that gathered more than 500 participants — including startups, investors, and accelerator representatives from around the world — and featured over 20 distinguished speakers. The conference provided a valuable platform to exchange

The AI MedLab team recently held a focused session to review recent progress and coordinate next steps. The meeting allowed team members to discuss ideas, align on priorities, and plan the immediate actions needed for the team’s projects. During the session, the team: – Discussed ways to improve coordination among

Recent strides in diabetes research have increasingly leveraged machine learning and deep learning techniques, marking a pivotal shift in understanding and managing this complex disease. A comprehensive bibliometric analysis from 2000 to 2022 has shed light on the evolving landscape of diabetes-related scientific literature, uncovering global trends and key insights

Recent research spanning from 1990 to 2023 has unveiled significant advancements in machine learning (ML) and artificial intelligence (AI) for predicting diabetic complications such as retinopathy (DR), kidney disease (DKD), and neuropathy (DN). Across 74 studies analyzed, a notable increase in global ML research emerged, particularly in DKD prediction. These

In the rapidly evolving landscape of medicine, the digital health revolution is spearheading transformative changes, particularly in diabetes care. A recent article in the Journal of Diabetes Science and Technology sheds light on groundbreaking innovations and technological advancements poised to revolutionize the management of this prevalent chronic disease. The article